BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 17200768)

  • 1. No interaction between factor V Leiden and hyperhomocysteinemia or MTHFR 677TT genotype in venous thrombosis. Results of a meta-analysis of published studies and a large case-only study.
    Keijzer MB; Borm GF; Blom HJ; Bos GM; Rosendaal FR; den Heijer M
    Thromb Haemost; 2007 Jan; 97(1):32-7. PubMed ID: 17200768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism.
    De Stefano V; Casorelli I; Rossi E; Zappacosta B; Leone G
    Semin Thromb Hemost; 2000; 26(3):305-11. PubMed ID: 11011848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study.
    Bezemer ID; Doggen CJ; Vos HL; Rosendaal FR
    Arch Intern Med; 2007 Mar; 167(5):497-501. PubMed ID: 17353498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolatereductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis.
    Keijzer MB; den Heijer M; Blom HJ; Bos GM; Willems HP; Gerrits WB; Rosendaal FR
    Thromb Haemost; 2002 Nov; 88(5):723-8. PubMed ID: 12428084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study.
    Oger E; Lacut K; Le Gal G; Couturaud F; Abalain JH; Mercier B; Mottier D;
    Thromb Res; 2007; 120(2):207-14. PubMed ID: 17126889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinemia and the compound heterozygous state for methylene tetrahydrofolate reductase are independent risk factors for deep vein thrombosis among South Indians.
    Naushad S; Jamal NJ; Angalena R; Prasad CK; Devi AR
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):113-7. PubMed ID: 17287626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation.
    Margaglione M; D'Andrea G; d'Addedda M; Giuliani N; Cappucci G; Iannaccone L; Vecchione G; Grandone E; Brancaccio V; Di Minno G
    Thromb Haemost; 1998 May; 79(5):907-11. PubMed ID: 9609218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhomocysteinemia: clinical and therapeutical involvement in venous thrombosis.
    Hoţoleanu C; Porojan-Iuga M; Rusu ML; Andercou A
    Rom J Intern Med; 2007; 45(2):159-64. PubMed ID: 18333369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies.
    Kim RJ; Becker RC
    Am Heart J; 2003 Dec; 146(6):948-57. PubMed ID: 14660985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
    González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Venous Thrombosis in Carriers of a Common Mutation in the Homocysteine Regulatory Enzyme Methylenetetrahydrofolate Reductase.
    Ocal IT; Sadeghi A; Press RD
    Mol Diagn; 1997 Mar; 2(1):61-68. PubMed ID: 10462593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
    Dölek B; Eraslan S; Eroğlu S; Kesim BE; Ulutin T; Yalçiner A; Laleli YR; Gözükirmizi N
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minor events and the risk of deep venous thrombosis.
    Eekhoff EM; Rosendaal FR; Vandenbroucke JP
    Thromb Haemost; 2000 Mar; 83(3):408-11. PubMed ID: 10744145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.
    Torres JD; Cardona H; Alvarez L; Cardona-Maya W; Castañeda SA; Quintero-Rivera F; Cadavid A; Bedoya G; Tobón L
    Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of homocysteine and MTHFR 677TT genotype and risk for venous thrombosis in a general population--results from the HUNT 2 study.
    Naess IA; Christiansen SC; Romundstad PR; Cannegieter SC; Blom HJ; Rosendaal FR; Hammerstrøm J
    Br J Haematol; 2008 May; 141(4):529-35. PubMed ID: 18318759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
    Procare-GEHT Group
    Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association between the C677T mutation in the 5,10-methylenetetrahydrofolate reductase gene and venous thromboembolism in Northwestern Greece.
    Zalavras ChG; Giotopoulou S; Dokou E; Mitsis M; Ioannou HV; Tzolou A; Kolaitis N; Vartholomatos G
    Int Angiol; 2002 Sep; 21(3):268-71. PubMed ID: 12384649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinemia and venous thrombosis: a meta-analysis.
    den Heijer M; Rosendaal FR; Blom HJ; Gerrits WB; Bos GM
    Thromb Haemost; 1998 Dec; 80(6):874-7. PubMed ID: 9869152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.
    Libourel EJ; Bank I; Meinardi JR; Baljé -Volkers CP; Hamulyak K; Middeldorp S; Koopman MM; van Pampus EC; Prins MH; Büller HR; van der Meer J
    Haematologica; 2002 Oct; 87(10):1068-73. PubMed ID: 12368162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene.
    Rintelen C; Mannhalter C; Lechner K; Eichinger S; Kyrle PA; Papagiannopoulos M; Schneider B; Pabinger I
    Blood Coagul Fibrinolysis; 1999 Mar; 10(2):101-5. PubMed ID: 10192659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.